Hangzhou Kanglaite Industry Company, Limited – Trademark Portfolio

Entity Type: 03

Hangzhou Kanglaite Industry Company, Limited holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. Currently, 1 trademark is registered. Notable registered marks include KANGLAITE. The owner is based in Zhejiang Province, P.R..

Daling Village, Zhoupu Town

Zhejiang Province, P.R. , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Hangzhou Kanglaite Industry Company, Limited's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Hangzhou Kanglaite Industry Company, Limited have?

Hangzhou Kanglaite Industry Company, Limited has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 cancelled.

What trademark classes does Hangzhou Kanglaite Industry Company, Limited file in?

Hangzhou Kanglaite Industry Company, Limited files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Hangzhou Kanglaite Industry Company, Limited's most well-known trademarks?

Hangzhou Kanglaite Industry Company, Limited's registered trademark portfolio includes well-known marks such as KANGLAITE. These are among 1 currently registered trademark in the portfolio.

What is Hangzhou Kanglaite Industry Company, Limited's trademark registration success rate?

Hangzhou Kanglaite Industry Company, Limited has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.